Gate2Brain
  • Home
  • Company
    • Mission & vision
    • Awards & Recognitions
    • Seals & Product Designations
    • Supported by
  • About us
    • Founders
    • Team
    • Advisory board
    • Values
  • Technology
    • Scientific Publications
  • Pipeline-Proof of Concept
  • Investors
  • News & Media
  • Contact
  • Menu Menu

Three University of Barcelona spin-offs receive funding from Women TechEU

Highlights, News
Three University of Barcelona spin-offs led by women will receive funding as part of the Women TechEU pilot callFundació Bosch i Gimpera

THREE UNIVERSITY OF BARCELONA SPIN-OFFS LED BY WOMEN WILL RECEIVE FUNDING AS PART OF THE WOMEN TechEU PILOT CALL.

NIMBLE Diagnostics, Gate2Brain and ColorSensing, spin-offs from the Universitat de Barcelona , ​​have been selected as part of the Women TechEU pilot call, a new European Union program that supports emerging Deep Tech companies led by women.

The three UB spin-offs will this year receive an individual grant of 75,000 euros to support the first steps of their innovation process and the growth of their company. In addition, they will be offered advice under the Women’s Leadership Program of the European Innovation Council and SMEs Executive Agency (EISMEA) and dedicated networking opportunities across the EU.

Source: http://www.fbg.ub.edu/actualitat/tres-spin-off-de-la-ub-liderades-per-dones-rebran-financament-en-el-marc-de-la-convocatoria-pilot-women-techeu/

December 15, 2022/by noticias
Tags: Biotech, Gate2Brain, Innovation, research, womenentrepreneur, WomenTechEu
Share this entry
  • Share on Facebook
  • Share on Twitter
  • Share on WhatsApp
  • Share on LinkedIn
  • Share by Mail
https://gate2brain.com/wp-content/uploads/2023/04/Captura-de-pantalla-2023-04-25-a-las-7.39.46.png 406 792 noticias https://gate2brain.com/wp-content/uploads/2020/12/Logo-Gate1Brain500pxGrueso.png noticias2022-12-15 15:31:512025-03-19 11:31:53Three University of Barcelona spin-offs receive funding from Women TechEU
You might also like
Sometimes drugs need a bigger push to be more effective and reach their final destination:ExpansionThe drug booster to the brain
Gate2Brain and its “molecular tractors” technology: new way to optimize the transport of drugs to the brain
Gate2Brain’s Summer Retreat 2024
THIS IS HOW A DRUG IS TOWED TO THE BRAINExpansiónTHIS IS HOW A DRUG IS TOWED TO THE BRAIN
2 year anniversaryGate2BrainGate2Brain 2 year highlights at a glance
Gate2Brain and Intact Barrier Brain Tumors: A Ray of Hope in the Fight against DIPG
PaidhosGate2Brain wants to deliver drugs to the brain to combat intact barrier brain tumors, such as DIPG
GATE2BRAIN winner of the Barcelona Activa Pre-acceleration competitionBarcelona ActivaGate2Brain winner of the Barcelona Activa Pre-Acceleration Competition

CATEGORIES

  • Advisory Board
  • Events
  • Funding & Breakthroughs
  • Interviews
  • Media & Press
  • Media Coverage
  • News
  • Podcasts
  • Press releases
  • Research & Publications
  • Sin categoría
  • Video Content

Events

  • Bioengineering the Future of Drug Delivery workshop – PortoApril 8, 2025 - 10:03
  • Gate2Brain at the 2nd Peptide-Based Therapeutics Summit | BostonMarch 26, 2025 - 15:34
  • 4YFN 2025March 6, 2025 - 19:45
  • Keystone Symposia on Drug Delivery to the Brain: Emerging ModalitiesFebruary 21, 2025 - 11:10
  • Gate2Brain at ACCELERATE 2025: A Decade of Impact and Future Innovations in Pediatric OncologyFebruary 20, 2025 - 10:19

SOCIAL

  • linkedin
  • youtube
Gate2Brain

Gate2Brain is a biotech company focused on the development of therapeutics that efficiently cross biological barriers such as the blood-brain barrier. We use a radically innovative peptide-based patented technology.

Where to find us

Barcelona Scientific Park
Baldiri Reixac, 4-8, Torre I
08028 Barcelona, Spain
info@gate2brain.com

Social

  • linkedin
  • youtube
© Copyright –Edisenius
  • Privacy Policy
  • Legal Notice
  • Cookie Policy
Sometimes the impossible only comes laterTHIS IS HOW A DRUG IS TOWED TO THE BRAINExpansiónTHIS IS HOW A DRUG IS TOWED TO THE BRAIN
Scroll to top
Manage Cookie Consent
This Website uses proprietary and third-party cookies to improve services and facilitate browsing. You can obtain further information about the cookies this site uses and how to limit them in the
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage vendors Read more about these purposes
View preferences
{title} {title} {title}